europe.chinadaily.com.cn
CIIE Showcases Healthcare Innovations
The 7th China International Import Expo showcased healthcare innovations from global companies like Lundbeck and Organon, with a focus on neuroscience, women's health, and advanced medical technologies.
English
China
TechnologyHealthHealthcareInnovationCollaborationImport Expo
LundbeckOrganonHaier GroupCapital Medical UniversityChina International Import Expo
Jens HoeyerZafer UnluerDong Yilang
- What was Organon's primary focus at the CIIE?
- Organon, a US-based pharmaceutical company, focused on women's reproductive health innovations at CIIE, aiming to address the needs of Chinese families and collaborate with local partners.
- What was Lundbeck's objective at this year's CIIE?
- Lundbeck, a Danish neuroscience pharmaceutical company, participated in CIIE for the first time, showcasing its treatments for brain diseases and aiming to introduce global innovations to China.
- What significant innovations did Incaier showcase at the expo?
- Incaier, Haier Group's healthcare arm, showcased over 40 innovative products and solutions at CIIE, including a prototype intravascular targeted temperature management system for stroke treatment.
- What was the overall impact of the seventh CIIE on the healthcare industry?
- CIIE's seventh edition attracted numerous leading pharmaceutical and medical device companies, launching many innovative health technologies and services in China.
- What is the main purpose of the China International Import Expo (CIIE) for healthcare companies?
- The China International Import Expo (CIIE) provides a platform for healthcare companies to showcase achievements and collaborate, expanding market opportunities.